由设计质量 (QbD) 驱动的开发和优化,用于治疗皮肤炎症的塔克罗利斯装载微乳液
Sanjida Ahmed Srishti1, Paromita Paul Pinky1, Ryan Taylor1
1School of Pharmacy, Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA 15282, USA.
Pharmaceutics
|January 8, 2025
概括
这项研究引入了一种新的微乳液,用于局部施用塔克罗利斯治疗皮肤炎症. 这种配方增强了药物的透和保留,可能改善患者对牛皮和湿疹等疾病的遵守.
科学领域:
- 制药科学 制药科学
- 皮肤病学 皮肤病学
- 材料科学 材料科学 材料科学
背景情况:
- 皮肤炎症是皮肤病如牛皮和湿疹的关键特征.
- 局部使用的tacrolimus是一种强大的免疫抑制剂,在治疗皮肤炎症方面表现出有效性.
- 微乳液通过改善难溶性药物的透和保留来提供增强的药物输送.
研究的目的:
- 开发和优化一种新的微乳液配方,用于局部施用塔克罗利斯.
- 通过改善输送来提高塔克罗利斯在控制皮肤炎症方面的疗效.
- 调查微乳液制造的设计质量 (QbD) 方法.
主要方法:
- 使用了一种新的微乳液制造工艺,结合了低能耗和高能耗的方法.
- 设计质量 (QbD) 方法,包括FMECA,DoE和MLR,用于优化.
- 最佳的微乳液配方以关键质量属性 (CQAs) 进行了表征,并扩大了规模.
主要成果:
- 使用QbD成功开发了一种具有优化塔克罗利斯负载的稳定微乳液.
- 优化的微乳液满足了所有关键质量属性 (CQA) 并具有可扩展性.
- 试验室研究表明,微乳液的药物释放简介缓慢且延长.
结论:
- 微乳液代表了一种有前途的新方法,用于用于皮肤炎症的局部施用塔克罗利斯.
- 结合的低能耗乳化和微流体化工艺可以产生稳定,强大的微乳液,滴滴大小小小.
- 这种QbD驱动的微乳液制造通过微流体化进行优化是一种新的方法,用于输送难溶性抗炎药物.
更多相关视频
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
186
09:42Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
7.4K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
